Novo Nordisk completes second Phase 3a trial with semaglutide
25 September 2015 | By Victoria White
The trial investigated the efficacy and safety of semaglutide compared with exenatide in 813 people with type 2 diabetes...
List view / Grid view
News
CHMP adopts positive opinion of azacitidine for elderly patients with AML
25 September 2015 | By Victoria White
The CHMP adopted a positive opinion for an expanded indication of azacitidine for the treatment of adult patients aged 65 years or older with acute myeloid leukaemia who are not eligible for haematopoietic stem cell transplantation...
CHMP recommends heart failure drug Entresto
25 September 2015 | By Victoria White
The CHMP has adopted a positive opinion for Novartis’ Entresto (sacubitril/valsartan), marking an important milestone towards the drug becoming available in the EU.
What is a biosimilar medicine? NHS England explains all in new publication
25 September 2015 | By Victoria White
The British Generic Manufacturers Association, the Association of the British Pharmaceutical Industry (ABPI), and the UK BioIndustry Association (BIA) have joined forces to welcome NHS England’s new publication “What is a biosimilar medicine?”.
Yusen Logistics opens Global Pharma Airfreight Gateway at Amsterdam Schiphol
The official opening ceremony was performed by Mr Hiromitsu Kuramoto, President of Yusen Logistics. Mr. Kuramoto joined with Yusen Logistics colleagues in welcoming guests including customers, Airport officials and Customs authorities at the inauguration event.
CHMP recommends mepolizumab for severe refractory eosinophilic asthma
24 September 2015 | By Victoria White
Mepolizumab is an anti-IL 5 monoclonal antibody that is delivered in a 100mg dose via subcutaneous injection every four weeks...
Sayana Press becomes first contraceptive in the UK for self-injection
24 September 2015 | By Victoria White
Sayana Press combines a long-acting, reversible, contraceptive with an all-in-one prefilled, single-use, non-reusable Uniject injection system...
EC approves Fexeric for the treatment of hyperphosphatemia
24 September 2015 | By Victoria White
Fexeric is approved for the control of elevated serum phosphorus levels in adults with chronic kidney disease, including both dialysis and pre-dialysis patients...
Novo Nordisk to build new manufacturing plant in Iran
24 September 2015 | By
The project is expected to last five years and represents a Novo Nordisk investment of approximately 70 million euros...
NICE recommends idelalisib for chronic lymphocytic leukaemia
24 September 2015 | By Victoria White
Idelalisib has been recommended in combination with rituximab for adults with chronic lymphocytic leukaemia (CLL) who have relapsed early...
Biosimilar ABP 215 meets endpoints in Phase 3 study in NSCLC
24 September 2015 | By Victoria White
ABP 215 is being developed as a biosimilar to bevacizumab, a recombinant immunoglobulin G1 (IgG1) monoclonal antibody (mAb)...
NICE recommends blood-thinning drug edoxaban
23 September 2015 | By Victoria White
NICE has issued its final recommendation for edoxaban to help prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation...
Roche’s IPF drug Esbriet approved in Switzerland
23 September 2015 | By Victoria White
In a Phase III study, significantly more patients who received Esbriet showed delayed progression of idiopathic pulmonary fibrosis (IPF) than those who received placebo...
Switching to once-daily Triumeq maintains HIV viral suppression
23 September 2015 | By Victoria White
A Phase IIIb/IV study demonstrated that viral suppression was non-inferior for patients switching to once-daily Triumeq from an antiretroviral therapy...
Turing to lower price of Daraprim amid controversy
23 September 2015 | By Victoria White
Turing, the company that increased the price of Daraprim by over 5000%, has said that the price of the drug will be lowered but has not confirmed what the new price will be...
